Renaissance Technologies’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,338
| Closed | -$23K | – | 4554 |
|
|
2022
Q3 | $23K | Sell |
3,338
-1,147
| -26% | -$7.9K | ﹤0.01% | 3883 |
|
|
2022
Q2 | $48K | Buy |
+4,485
| New | +$48K | ﹤0.01% | 4002 |
|
|
2021
Q3 | – | Sell |
-4,098
| Closed | -$326K | – | 3983 |
|
|
2021
Q2 | $326K | Buy |
+4,098
| New | +$326K | ﹤0.01% | 3119 |
|
|
2021
Q1 | – | Sell |
-993
| Closed | -$158K | – | 3846 |
|
|
2020
Q4 | $158K | Sell |
993
-495
| -33% | -$78.8K | ﹤0.01% | 3192 |
|
|
2020
Q3 | $157K | Sell |
1,488
-770
| -34% | -$81.2K | ﹤0.01% | 3152 |
|
|
2020
Q2 | $274K | Sell |
2,258
-1,012
| -31% | -$123K | ﹤0.01% | 3072 |
|
|
2020
Q1 | $256K | Sell |
3,270
-143
| -4% | -$11.2K | ﹤0.01% | 3029 |
|
|
2019
Q4 | $1.01M | Buy |
3,413
+2,905
| +572% | +$855K | ﹤0.01% | 2627 |
|
|
2019
Q3 | $92K | Buy |
+508
| New | +$92K | ﹤0.01% | 3268 |
|
|
2018
Q3 | – | Sell |
-250
| Closed | -$171K | – | 3635 |
|
|
2018
Q2 | $171K | Buy |
+250
| New | +$171K | ﹤0.01% | 3097 |
|